Research & Literature

Severe right heart failure in a patient with chronic obstructive lung disease: a diagnostic challenge.

Meysman M, Pipeleers-Marichal M, Geers C, et al.

The Indian journal of chest diseases & allied sciences 2013; (55(3)):159-62.

Mitomycin-Induced Pulmonary Veno-Occlusive Disease: Evidence From Human Disease and Animal Models.

Perros F, Günther S, Ranchoux B, et al.

Circulation 2015; (132(9)):834-47 doi:10.1161/CIRCULATIONAHA.115.014207.

Pulmonary veno-occlusive disease: a rare cause of pulmonary hypertension in systemic sclerosis. Case presentation and review of the literature .

Daraban AM, Enache R, Predescu L, et al.

Romanian journal of internal medicine = Revue roumaine de medecine interne 2015; (53(2)):175-83 doi:10.1515/rjim-2015-0024.

Occupational exposure to organic solvents: a risk factor for pulmonary veno-occlusive disease.

Montani D, Lau EM, Descatha A, et al.

The European respiratory journal 2015; (46(6)):1721-31 doi:10.1183/13993003.00814-2015.

Genetic counselling in a national referral centre for pulmonary hypertension.

Girerd B, Montani D, Jaïs X, et al.

The European respiratory journal 2016; (47(2)):541-52 doi:10.1183/13993003.00717-2015.

Pulmonary veno-occlusive disease.

Montani D, Lau EM, Dorfmüller P, et al.

The European respiratory journal 2016; (47(5)):1518-34 doi:10.1183/13993003.00026-2016.

Small Sample Lung Biopsy Findings in Patients With Clinicoradiologic Suspicion of Pulmonary Venoocclusive Disease-Pulmonary Capillary Hemangiomatosis.

Bal SK, Thangakunam B, Irodi A, et al.

Journal of bronchology & interventional pulmonology 2016; (23(4)):308-315 doi:10.1097/LBR.0000000000000320.

EIF2AK4 mutation in pulmonary veno-occlusive disease: A case report and review of the literature.

Liang L, Ma G, Chen K, et al.

Medicine 2016; (95(39)):e5030 doi:10.1097/MD.0000000000005030.

Pulmonary hypertension secondary to pulmonary veno-occlusive disease complicated by right heart failure, hypotension and acute kidney injury.

Golzy N, Fernandes S, Sharim J, et al.

Respiratory medicine case reports 2017; (20()):10-13 doi:10.1016/j.rmcr.2016.09.005.

Clinical phenotypes and outcomes of heritable and sporadic pulmonary veno-occlusive disease: a population-based study.

Montani D, Girerd B, Jaïs X, et al.

The Lancet. Respiratory medicine 2017; (5(2)):125-134 doi:10.1016/S2213-2600(16)30438-6.

A case report of PVOD patient combined with pulmonary embolism: Anticoagulation or not?

Yuan X, Hou X, Guo W, et al.

Medicine 2017; (96(13)):e6507 doi:10.1097/MD.0000000000006507.

Variable Expressivity of a Founder Mutation in the EIF2AK4 Gene in Hereditary Pulmonary Veno-occlusive Disease and Its Impact on Survival.

Navas Tejedor P, Palomino Doza J, Tenorio Castaño JA, et al.

Revista espanola de cardiologia (English ed.) 2018; (71(2)):86-94 doi:10.1016/j.rec.2017.03.034.

Heritable pulmonary hypertension: from bench to bedside.

Girerd B, Weatherald J, Montani D, Humbert M

European respiratory review : an official journal of the European Respiratory Society 2017; (26(145)) doi:10.1183/16000617.0037-2017.

Pulmonary veno-occlusive disease: An important consideration in patients with pulmonary hypertension.

Balko R, Edriss H, Nugent K, Test V

Respiratory medicine 2017; (132()):203-209 doi:10.1016/j.rmed.2017.10.015.

[Pulmonary veno-occlusive disease].

Boucly A, Girerd B, Bourlier D, et al.

Revue des maladies respiratoires 2018; (35(2)):160-170 doi:10.1016/j.rmr.2017.11.005.

Clinical prediction score for identifying patients with pulmonary veno-occlusive disease/pulmonary capillary hemangiomatosis.

Ogawa A, Takahashi Y, Matsubara H

Journal of cardiology 2018; (72(3)):255-260 doi:10.1016/j.jjcc.2018.02.009.

Pulmonary veno-occlusive disease: pathogenesis, risk factors, clinical features and diagnostic algorithm - state of the art.

Szturmowicz M, Kacprzak A, Szołkowska M, et al.

Advances in respiratory medicine 2018; (86(3)) doi:10.5603/ARM.2018.0021.

Lung transplantation as a viable option of treatment for pulmonary veno-occlusive disease.

Ochman M, Urlik M, Tatoj Z, et al.

Advances in respiratory medicine 2018; (86(5)):249-254 doi:10.5603/ARM.2018.0040.

Use of vasodilators for the treatment of pulmonary veno-occlusive disease and pulmonary capillary hemangiomatosis: A systematic review.

Ogawa A, Sakao S, Tanabe N, et al.

Respiratory investigation 2019; (57(2)):183-190 doi:10.1016/j.resinv.2018.10.004.

Comprehensive three-dimensional morphology of neoangiogenesis in pulmonary veno-occlusive disease and pulmonary capillary hemangiomatosis.

Neubert L, Borchert P, Shin HO, et al.

The journal of pathology. Clinical research 2019; (5(2)):108-114 doi:10.1002/cjp2.125.

Computed tomographic and clinical features of pulmonary veno-occlusive disease: raising the radiologist's awareness.

Ali N, Loughborough WW, Rodrigues JCL, et al.

Clinical radiology 2019; (74(9)):655-662 doi:10.1016/j.crad.2019.04.023.

Targeted therapy in pulmonary veno-occlusive disease: time for a rethink?

Luo Q, Jin Q, Zhao Z, et al.

BMC pulmonary medicine 2019; (19(1)):257 doi:10.1186/s12890-019-1031-3.

Pulmonary capillary haemangiomatosis: a distinct entity?

Weatherald J, Dorfmüller P, Perros F, et al.

European respiratory review : an official journal of the European Respiratory Society 2020; (29(156)) doi:10.1183/16000617.0168-2019.

Characteristics and Long-term Outcomes of Pulmonary Venoocclusive Disease Induced by Mitomycin C.

Certain MC, Chaumais MC, Jaïs X, et al.

Chest 2021; (159(3)):1197-1207 doi:10.1016/j.chest.2020.09.238.

A case report, a case who developed limited cutaneous scleroderma and pulmonary hypertension 8 years after diagnosis of anti-centromere antibody-positive Sjögren syndrome.

Kyono M, Okamoto M, Sakamoto S, et al.

Modern rheumatology case reports 2020; (4(2)):248-252 doi:10.1080/24725625.2020.1755516.

Case report: pulmonary veno-occlusive disease: a rare but fatal cause of pulmonary hypertension in a patient following allogeneic stem cell transplantation.

Katrien M, Dieter S, Anke D, et al.

Acta clinica Belgica 2022; (77(3)):697-702 doi:10.1080/17843286.2021.1945352.

Pulmonary veno-occlusive disease in childhood-a rare disease not to be missed.

Pfluger M, Humpl T

Cardiovascular diagnosis and therapy 2021; (11(4)):1070-1079 doi:10.21037/cdt-20-320.

Veno-occlusive disease of the lung after allogeneic haematopoietic stem-cell transplantation: An autopsy study.

Kreft A, Alverson C, Wagner-Drouet EM, et al.

Pathology, research and practice 2022; (231()):153799 doi:10.1016/j.prp.2022.153799.

Pulmonary veno-occlusive disease in a patient with recently diagnosed systemic sclerosis.

van Leeuwen NM, Ramiro S, Ninaber MK, et al.

Journal of scleroderma and related disorders 2020; (5(2)):NP1-NP4 doi:10.1177/2397198319852194.

Diagnosis and Treatment of Pulmonary Arterial Hypertension: A Review.

Ruopp NF, Cockrill BA

JAMA 2022; (327(14)):1379-1391 doi:10.1001/jama.2022.4402.

The role of cardiopulmonary exercise testing in identifying and monitoring pulmonary veno-oclusive disease: a case report with ING.

Segura de la Cal T, Pérez-Olivares C, Cristo Ropero MJ, et al.

European heart journal. Case reports 2022; (6(5)):ytac138 doi:10.1093/ehjcr/ytac138.

Patient-specific and gene-corrected induced pluripotent stem cell-derived endothelial cells elucidate single-cell phenotype of pulmonary veno-occlusive disease.

Ma B, Li T, Li W, et al.

Stem cell reports 2022; (17(12)):2674-2689 doi:10.1016/j.stemcr.2022.10.014.

Efficacy and safety of oral pulmonary vasodilators in pulmonary veno-occlusive disease.

Nakamura J, Tsujino I, Shima H, et al.

Pulmonary circulation 2022; (12(4)):e12168 doi:10.1002/pul2.12168.

Pulmonary Veno-Occlusive Disease after Autologous Stem Cell Transplantation.

Hamada T, Takahashi H, Nakagawa M, et al.

Case reports in oncology 2023; (16(1)):338-346 doi:10.1159/000530265.

Acute venodilation properties of low-dose intravenous nitroglycerine in pulmonary veno-occlusive disease: a case report.

Maruyama H, Sakai S, Suzuki S

European heart journal. Case reports 2023; (7(8)):ytad365 doi:10.1093/ehjcr/ytad365.

Diagnosis and management of pulmonary veno-occlusive disease.

Solinas S, Boucly A, Beurnier A, et al.

Expert review of respiratory medicine 2023; (17(8)):635-649 doi:10.1080/17476348.2023.2247989.

A Challenging Case of Genetically and Histologically Diagnosed Pulmonary Veno-Occlusive Disease with Extracorporeal Life Support and Redo Lung Transplantation.

Laimoud M, Alanazi Z, Alahmadi F, Aldalaan A

Case reports in cardiology 2023; (2023()):4846338 doi:10.1155/2023/4846338.

Lung transplantation in primary pulmonary arterial hypertension and pulmonary venous hypertension.

Sainathan S, Ryan J, Mullinari L, Sanchez P

Clinical transplantation 2024; (38(1)):e15158 doi:10.1111/ctr.15158.

Outcomes and risk assessment in pulmonary veno-occlusive disease.

Boucly A, Solinas S, Beurnier A, et al.

ERJ open research 2024; (10(1)) doi:10.1183/23120541.00612-2023.

Pulmonary veno-occlusive disease: illustrative cases and literature review.

Lechartier B, Boucly A, Solinas S, et al.

European respiratory review : an official journal of the European Respiratory Society 2024; (33(171)) doi:10.1183/16000617.0156-2023.

Pulmonary Arterial Hypertension with Features of Venous Involvement: A Detective's Task.

Cazeiro DI, Plácido R, Raposo MA, et al.

Arquivos brasileiros de cardiologia 2024; (121(4)):e20230565 doi:10.36660/abc.20230565.

Long-term sildenafil therapy for pulmonary veno-occlusive disease in association with melphalan therapy for multiple myeloma: A case report.

Hesse C, Kovacs G, Scheidl S, Olschewski H

SAGE open medical case reports 2024; (12()):2050313X241292529 doi:10.1177/2050313X241292529.

Pulmonary veno-occlusive disease: A systematic review of risk factors, clinical presentation, diagnostic investigations, treatment outcomes and prognostic factors.

Thong LP, Hakak-Zargar B, Burns AT, et al.

Journal of medical imaging and radiation oncology 2025; (69(2)):186-197 doi:10.1111/1754-9485.13814.

Pulmonary veno-occlusive disease: a clinical review.

Deshwal H, Sarkar S, Basu A, Jalil BA

Breathe (Sheffield, England) 2025; (21(1)):240098 doi:10.1183/20734735.0098-2024.

Bridging knowledge gaps: A case report of pulmonary Veno-occlusive disease in systemic sclerosis.

Garg S, Gupta D, Sindwani G

Lung India : official organ of Indian Chest Society 2025; (42(3)):248-251 doi:10.4103/lungindia.lungindia_481_24.

Pulmonary veno-occlusive disease: a paradigm of diagnosis and therapeutic challenges in pulmonary hypertension.

Aguado B, Grynblat J, Budhram B, et al.

Current opinion in pulmonary medicine 2025; (31(5)):443-455 doi:10.1097/MCP.0000000000001184.

The landscape of referrals for lung transplantation in pulmonary arterial hypertension: A report from the Pulmonary Hypertension Association Registry.

Kolaitis NA, Singer JP, Bartolome S, et al.

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 2026; (45(1)):125-136 doi:10.1016/j.healun.2025.06.019.

Pulmonary veno-occlusive disease: Insights from animal models.

Hata A, Gur B, Kalra J, Prabhakar A

Vascular pharmacology 2025; (161()):107547 doi:10.1016/j.vph.2025.107547.

Pulmonary Veno-occlusive Disease in a Military Pilot: Case Report and Mini-review.

Radchenko G, Botsiuk Y, Dyadyk O, et al.

Current cardiology reviews 2026; (22(5)):e1573403X412872 doi:10.2174/011573403X412872251107111309.

Impact of Pulmonary Veno-Occlusive Disease on Posttransplant Survival in Pulmonary Hypertension.

Manso Tejerina P, Loaiza Q, Andrés C, et al.

Clinical transplantation 2026; (40(3)):e70493 doi:10.1111/ctr.70493.

Revisiting REVEAL-ECHO: A Focus on Pulmonary Veno-Occlusive Disease.

Gutiérrez-Ortiz E, Jiménez López-Guarch C, Cruz-Utrilla A, et al.

Archivos de bronconeumologia 2026; doi:10.1016/j.arbres.2026.05.002.

Identification of pulmonary arterial hypertension patients with venous or capillary involvement.

Andruska AM, Cruz-Utrilla A, Nossent EJ, et al.

American journal of respiratory and critical care medicine 2026; (212(9)):2199-2210 doi:10.1093/ajrccm/aamag289.

Pulmonary venoocclusive disease/pulmonary capillary hemangiomatosis: Inadequacy of clinico-radiologic features in diagnosis.

Hurst P, White D, Ryu JH, et al.

Human pathology 2026; (177()):106203 doi:10.1016/j.humpath.2026.106203.

Pulmonary Veno-Occlusive Disease: A Focused Clinicopathologic Series.

Sedhai YR, Kattih Z, Thomas CA, et al.

Pulmonary circulation 2026; (16(3)):e70365 doi:10.1002/pul2.70365.

Pulmonary Hypertension Under the Microscope: What Histopathology Means for Diagnosis and Treatment.

Dagan M, Nanayakkara S, Chan W, et al.

Chest 2026; doi:10.1016/j.chest.2026.07.5215.